Immucell (ICCC) Other Working Capital Changes (2010 - 2025)
Immucell's (ICCC) quarterly Other Working Capital Changes came in at -$177129.0 in Q4 2025, down 4063.5% YoY from $4469.0 in Q4 2024, and down 209.88% on a QoQ basis from $161196.0 in Q3 2025.
Immucell (ICCC) Other Working Capital Changes (2010 - 2025) Analysis & Trends
Immucell (ICCC) has 16 years of Other Working Capital Changes data on file, last reported at -$177129.0 in Q4 2025.
- Quarterly Other Working Capital Changes fell 4063.5% year-over-year to -$177129.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4318.0 (up 117.78% YoY) and the FY2025 annual result came in at $4318.0, up 117.78% from the prior year.
- Other Working Capital Changes declined to -$177129.0 in Q4 2025, from $161196.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $327569.0 in Q1 2023 to a low of -$277244.0 in Q2 2023.
- A 5-year average of -$724.65 and a median of -$2951.5 in 2021 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes soared 10612.48% — and 2025, when it plunged 4063.5%.
- Tracing ICCC's Other Working Capital Changes over 5 years: stood at -$195298.0 in 2021, then surged by 126.66% to $52061.0 in 2022, then plunged by 123.79% to -$12386.0 in 2023, then surged by 136.08% to $4469.0 in 2024, then sank by 4063.5% to -$177129.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$177129.0 (Q4 2025), $161196.0 (Q3 2025), and $8202.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -177,129.00 |
| Dec 31, 2025 | -177,129.00 |
| Dec 31, 2025 | -177,129.00 |
| Sep 30, 2025 | 161,196.00 |
| Sep 30, 2025 | 161,196.00 |
| Sep 30, 2025 | 161,196.00 |
| Jun 30, 2025 | 8,202.00 |
| Jun 30, 2025 | 8,202.00 |
| Jun 30, 2025 | 8,202.00 |
| Mar 31, 2025 | 12,049.00 |
| Mar 31, 2025 | 12,049.00 |
| Mar 31, 2025 | 12,049.00 |
| Dec 31, 2024 | 4,469.00 |
| Dec 31, 2024 | 4,469.00 |
| Dec 31, 2024 | 4,469.00 |
| Sep 30, 2024 | -8,780.00 |
| Sep 30, 2024 | -8,780.00 |
| Sep 30, 2024 | -8,780.00 |
| Jun 30, 2024 | -8,569.00 |
| Jun 30, 2024 | -8,569.00 |